Laure Monard

4PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 03, 2026
Impact of Tumor Genomic Profile on Adjuvant Chemotherapy Efficacy in Resected Pancreatic Adenocarcinoma: Results From the PRODIGE-24/CCTG PA6 Study.

|Jul 15, 2026
HPV16 genomic status stratifies risk of disease recurrence in oropharyngeal squamous cell carcinoma.

|Jan 22, 2026
Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial.

Haitham Mirghani, Anne Aupérin, Caroline Even

|Aug 26, 2022
Preneoplastic Lesions in Surgical Specimens Do Not Worsen the Prognosis of Patients Who Underwent Surgery for Pancreatic Adenocarcinoma: Post-Hoc Analysis of the PRODIGE 24-CCTG PA 6 Trial.

Théo Legrand, Julia Salleron, Thierry Conroy

Pageof 1

Frequent Collaborators

2 joint publications

Thierry Conroy

2 joint publications

Aurélien Lambert

2 joint publications

Haitham Mirghani

2 joint publications

Anne Aupérin